Last Action | to Health & Welfare (S) |
---|---|
Title | AN ACT relating to abuse-deterrent opioid analgesic drug products. |
Bill Documents |
Bill
|
Impact Statements | Health Mandate |
Bill Request Number | 990 |
Sponsors | A. Wuchner, J. Jenkins, L. Belcher, K. Flood, R. Huff, K. King, M. King, M. Marzian, D. Mayfield, M. Rader, R. Smart, D. St. Onge, S. Westrom, J. York |
Summary of Original Version | Create a new section of KRS Chapter 217 to define terms, prohibit substitution or dispensing an equivalent drug product without documentation from a prescribing health care practitioner; create a new section of subtitle 17A of KRS Chapter 304 to define terms and limit cost sharing for generic abuse-deterrent opioid analgesic drug products; create a new section of KRS Chapter 205 to permit Medicaid compliance. |
Index Headings of Original Version |
Health Benefit Mandate - Abuse-deterrent opioid analgesic drug product, substitution Drugs and Medicines - Abuse-deterrent opioid analgesic drug product, substitution Health and Medical Services - Abuse-deterrent opioid analgesic drug product, substitution Hospitals and Nursing Homes - Abuse-deterrent opioid analgesic drug product, substitution Insurance, Health - Abuse-deterrent opioid analgesic drug product, substitution Pharmacists - Abuse-deterrent opioid analgesic drug product, substitution Physicians and Practitioners - Abuse-deterrent opioid analgesic drug product, substitution Public Medical Assistance - Abuse-deterrent opioid analgesic drug product, substitution Substance Abuse - Abuse-deterrent opioid analgesic drug product, substitution Medicaid - Abuse-deterrent opioid analgesic drug product, substitution |
Proposed Amendments |
House Committee Substitute 1 House Floor Amendment 1 |
Votes | Vote History |
02/02/16 |
|
---|---|
02/04/16 |
|
03/10/16 |
|
03/11/16 |
|
03/14/16 |
|
03/15/16 |
|
03/18/16 |
|
03/21/16 |
|
03/23/16 |
|
03/24/16 |
|
Amendment | House Committee Substitute 1 |
---|---|
Impact Statements | Health Mandate |
Summary | Amend to delete insurer. |
Index Headings |
Health Benefit Mandate - Abuse-deterrent opioid analgesic drug product, substitution Drugs and Medicines - Abuse-deterrent opioid analgesic drug product, substitution Health and Medical Services - Abuse-deterrent opioid analgesic drug product, substitution Hospitals and Nursing Homes - Abuse-deterrent opioid analgesic drug product, substitution Insurance, Health - Abuse-deterrent opioid analgesic drug product, substitution Pharmacists - Abuse-deterrent opioid analgesic drug product, substitution Physicians and Practitioners - Abuse-deterrent opioid analgesic drug product, substitution Public Medical Assistance - Abuse-deterrent opioid analgesic drug product, substitution Substance Abuse - Abuse-deterrent opioid analgesic drug product, substitution Medicaid - Abuse-deterrent opioid analgesic drug product, substitution |
Amendment | House Floor Amendment 1 |
---|---|
Sponsor | A. Wuchner |
Summary | Amend to encourage coverage of two and require coverage of one abuse-deterrent opioid analgesic drug products. |
Index Headings |
Health Benefit Mandate - Abuse-deterrent opioid analgesic drug product, substitution Drugs and Medicines - Abuse-deterrent opioid analgesic drug product, substitution Health and Medical Services - Abuse-deterrent opioid analgesic drug product, substitution Hospitals and Nursing Homes - Abuse-deterrent opioid analgesic drug product, substitution Insurance, Health - Abuse-deterrent opioid analgesic drug product, substitution Pharmacists - Abuse-deterrent opioid analgesic drug product, substitution Physicians and Practitioners - Abuse-deterrent opioid analgesic drug product, substitution Public Medical Assistance - Abuse-deterrent opioid analgesic drug product, substitution Substance Abuse - Abuse-deterrent opioid analgesic drug product, substitution Medicaid - Abuse-deterrent opioid analgesic drug product, substitution |
Last updated: 1/16/2019 3:08 PM (EST)